Table 1.

Cohort Characteristics

Characteristic	Total population (n = 250)
Age, median (IQR)	36 (30–43)
Female, n (%)	169 (68%)
Nadir CD4 count, median (IQR)	224 (144–292)
Most recent CD4 count, median (IQR)	466 (341–624)
Duration on ART in years, median (IQR)	2.6 (2.5–2.7)
ART regimen
TDF/3TC/EFV, n (%)	129 (51.6)
AZT/3TC/NVP, n (%)	68 (27.2)
AZT/3TC/EFV, n (%)	48 (19.2)
TDF/3TC/NVP, n (%)	5 (2.0)
Change in weight from ART initiation date in kilograms, mean (SD)	1.56 (6.9)
Evidence of lipodystrophy, n (%)	19 (7.6)

3TC, lamivudine; ART, antiretroviral therapy; BMI, Body Mass Index; EFZ, efavirenz; IQR, inter quartile range; NVP, nevirapine; TDF, tenofovir.